Carmine Therapeutics
Carmine Therapeutics's Overview
Carmine Therapeutics is a biotechnology company focused on harnessing the unique properties of red blood cell extracellular vesicles (RBCEVs) to develop powerful, non-viral gene therapies. Their proprietary REGENT™ platform aims to overcome the limitations of current viral-based gene therapies, offering the potential for repeat dosing, larger payload capacity, and a better safety profile. Carmine is advancing a pipeline of therapeutics for a range of genetic and rare diseases, with a mission to deliver transformative treatments to patients in need.
Where is Carmine Therapeutics's Headquarters?
HQ Function
Serves as the primary center for corporate strategy, research leadership, business development, clinical operations, and administrative functions.
Notable Features:
Situated within a vibrant biotech hub, providing access to state-of-the-art laboratory facilities and a collaborative ecosystem of research institutions and partner companies.
Work Culture:
A science-driven, innovative, and collaborative environment. Employees are typically passionate about advancing gene therapy and making a difference in patients' lives, working in a fast-paced, dynamic setting.
HQ Significance:
The Cambridge location provides unparalleled access to top-tier talent, leading academic research, venture capital, and potential pharmaceutical partners, crucial for a pioneering biotech firm.
Values Reflected in HQ: Innovation, scientific rigor, collaboration, and a commitment to translating cutting-edge science into patient therapies.
Location:
Carmine Therapeutics operates with key research and development hubs in North America (Cambridge, MA) and Asia (Singapore). This dual presence allows them to leverage talent, resources, and collaborative opportunities in two major global biotech centers, supporting their efforts in platform development, pipeline advancement, and strategic partnerships worldwide.
Street Address:
200 Technology Square, Suite 230
City:
Cambridge
State/Province:
MA
Country:
USA
Carmine Therapeutics's Global Presence
Singapore, Singapore
Address: Discovery Centre, 45 Nanyang Drive, #02-02, Singapore 637460 (Note: This is an address associated with EVX Ventures, a key founder/investor; specific Carmine R&D site in Singapore may be within a research park like Biopolis or associated with NUS Enterprise)
To advance core RBCEV technology, foster collaborations within the Asia-Pacific biotech ecosystem, and support global R&D programs. Taps into Singapore's strong biomedical research infrastructure.
Buying Intent Signals for Carmine Therapeutics
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Executive Team of Carmine Therapeutics
As of April 2025, Carmine Therapeutics' leadership includes:
Investors of Carmine Therapeutics
Carmine Therapeutics has been backed by several prominent investors over the years, including:
Executive New Hires/Exits in the Last 12 Months
In the past 12-18 months, Carmine Therapeutics appointed its co-founder Xingfeng Bao as CEO and strengthened its clinical development capabilities with the hiring of Eliseo Salinas as Chief Development Officer.
Departures
New Appointments:
Technology (Tech Stack) used by Carmine Therapeutics
Discover the tools Carmine Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Carmine Therapeutics Email Formats and Examples
While not publicly confirmed, biotechnology companies of Carmine Therapeutics's size often use common email patterns. The most likely format is [first_initial][last]@carminetherapeutics.com or [first].[last]@carminetherapeutics.com.
[first_initial][last]@carminetherapeutics.com
Format
xbao@carminetherapeutics.com
Example
70%
Success rate
News and media
PR Newswire • May 16, 2023
Carmine Therapeutics Appoints Eliseo Salinas, MD, MSc, as Chief Development Officer
Carmine Therapeutics announced the appointment of Eliseo Salinas, MD, MSc, as its Chief Development Officer. Dr. Salinas brings extensive experience in clinical development and regulatory affairs to lead Carmine's efforts in advancing its novel gene therapies through clinical trials....more
PR Newswire • January 05, 2023
Carmine Therapeutics Appoints Co-Founder Xingfeng Bao, Ph.D., as Chief Executive Officer
Carmine Therapeutics announced that its Board of Directors has appointed Co-founder Xingfeng Bao, Ph.D., as Chief Executive Officer, effective immediately. He succeeds Don Haut, Ph.D., who will transition from the Company....more
Takeda • March 30, 2021
Carmine Therapeutics and Takeda Announce Research Collaboration to Develop and Commercialize Non-Viral Gene Therapies for Two Rare Diseases
Carmine Therapeutics and Takeda Pharmaceutical Company Limited announced a research collaboration and license agreement to discover, develop, and commercialize non-viral gene therapies for two rare disease targets using Carmine's REGENT™ Platform. The deal included upfront payment, milestones up to $900M and royalties....more
Highperformr’s free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including Carmine Therapeutics, are just a search away.